Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study-Reference-Cited by-同舟云学术

Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study

Published:2022-05 Issue:5 Volume:21 Page:428-437
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

De Cock Valérie Cochen,Dodet Pauline,Leu-Semenescu Smaranda,Aerts Cécile,Castelnovo Giovanni,Abril Beatriz,Drapier Sophie,Olivet Hélène,Corbillé Anne-Gaëlle,Leclair-Visonneau Laurène,Sallansonnet-Froment Magali,Lebouteux Marie,Anheim Mathieu,Ruppert Elisabeth,Vitello Nicolas,Eusebio Alexandre,Lambert Isabelle,Marques Ana,Fantini Maria Livia,Devos David,Monaca Christelle,Benard-Serre Nicolas,Lacombe Sandy,Vidailhet Marie,Arnulf Isabelle,Doulazmi Mohamed,Roze Emmanuel

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference35 articles.

1. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease;Martinez-Martin;Mov Disord,2011

2. Insomnia in Parkinson's disease: frequency and progression over time;Gjerstad;J Neurol Neurosurg Psychiatry,2007

3. Pharmacological insights into the use of apomorphine in Parkinson's disease: clinical relevance;Auffret;Clin Drug Investig,2018

4. Continuous subcutaneous apomorphine infusion in advanced Parkinson's disease: 10-year experience with 230 patients;Sesar;J Neurol,2017

5. Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study;García Ruiz;Mov Disord,2008

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sleep and sleep disorders in people with Parkinson's disease;The Lancet Neurology;2024-09

2. Insomnia in Parkinson’s Disease: Causes, Consequences, and Therapeutic Approaches;Molecular Neurobiology;2024-08-05

3. Influence of continuous subcutaneous apomorphine infusion on cognition and behavior in Parkinson's disease: A systematic review;Revue Neurologique;2024-08

4. Subcutaneous Levodopa: A New Engine for the Vintage Molecule;Neurology and Therapy;2024-06-14

5. Effects of dopaminergic therapy on sleep quality in fluctuating Parkinson’s disease patients;Journal of Neurology;2024-04-12